Since our founding in 1935, Morgan Stanley has consistently delivered first-class business in a first-class way. We offer scalable investment products, foster innovative solutions and provide actionable insights across sustainability issues.įrom our startup lab to our cutting-edge research, we broaden access to capital for diverse entrepreneurs and spotlight their success. We provide comprehensive workplace financial solutions for organizations and their employees, combining personalized advice with modern technology. We deliver active investment strategies across public and private markets and custom solutions to institutional and individual investors. We offer timely, integrated analysis of companies, sectors, markets and economies, helping clients with their most critical decisions. Global institutions, leading hedge funds and industry innovators turn to Morgan Stanley for sales, trading and market-making services. We have global expertise in market analysis and in advisory and capital-raising services for corporations, institutions and governments. We help people, businesses and institutions build, preserve and manage wealth so they can pursue their financial goals. Morgan Stanley helps people, institutions and governments raise, manage and distribute the capital they need to achieve their goals. Hear their stories and learn about how they are redefining the terms of success.
Multicultural and women entrepreneurs are the cutting-edge leaders of businesses that power markets. Our insightful research, advisory and investing capabilities give us unique and broad perspective on sustainability topics.
Stay abreast of the latest trends and developments.
#Stock icons drug discovery software
Whether it’s hardware, software or age-old businesses, everything today is ripe for disruption.
#Stock icons drug discovery how to
Learn from our industry leaders about how to manage your wealth and help meet your personal financial goals.įrom volatility and geopolitics to economic trends and investment outlooks, stay informed on the key developments shaping today's markets.
Across all our businesses, we offer keen insight on today's most critical issues. Relying on a half-century of experience in the discovery and development of drug candidates, we work with pharmaceutical companies and government agencies to bring new medicines to market, and to ensure the safety and efficacy of those in the marketplace.At Morgan Stanley, we lead with exceptional ideas. We also support natural products discovery and hit generation using in-house focused libraries. Our scientists also provide computational chemistry and bioinformatics support. We conduct medicinal chemistry–driven lead optimization campaigns to convert low potency/efficacy compounds with liabilities into preclinical candidates that can enter IND-enabling studies.
We apply integrated drug development capabilities in drug metabolism and pharmacokinetics, toxicology, bioanalysis, and analytical and formulation development to support development of drug candidates from hit identification to lead optimization and proof of principle. Our team leverages core expertise in assay development, high-throughput screening (HTS), hit-to-lead medicinal chemistry, molecular design, in vitro ADME, and in vivo pharmacokinetics (PK) to expedite the drug discovery process.
0 kommentar(er)
